P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation.

Molecular Biology of the Cell
Ping LiMasaki Inagaki

Abstract

The ataxia telangiectasia mutated- and rad3-related kinase (ATR)/Chk1 pathway is a sentinel of cell cycle progression. On the other hand, the Ras/mitogen-activated protein kinase/90-kDa ribosomal S6 kinase (p90 RSK) pathway is a central node in cell signaling downstream of growth factors. These pathways are closely correlated in cell proliferation, but their interaction is largely unknown. Here we show that Chk1 is phosphorylated predominantly at Ser-280 and translocated from cytoplasm to nucleus in response to serum stimulation. Nonphosphorylated Chk1-Ser-280 mutation attenuates nuclear Chk1 accumulation, whereas the phosphomimic mutation has a reverse effect on the localization. Treatment with p90 RSK inhibitor impairs Chk1 phosphorylation at Ser-280 and accumulation at the nucleus after serum stimulation, whereas these two phenomena are induced by the expression of the constitutively active mutant of p90 RSK in serum-starved cells. In vitro analyses indicate that p90 RSK stoichiometrically phosphorylates Ser-280 on Chk1. Together with Chk1 phosphorylation at Ser-345 by ATR and its autophosphorylation at Ser-296, which are critical for checkpoint signaling, Chk1-Ser-280 phosphorylation is elevated in a p90 RSK-dependent manne...Continue Reading

References

Apr 30, 1998·Advances in Cancer Research·T S LewisN G Ahn
Nov 27, 1999·The Journal of Biological Chemistry·Y TanM J Comb
Jun 8, 2001·Molecular and Cellular Biology·H Zhao, H Piwnica-Worms
Jun 14, 2002·Current Biology : CB·Emma ShtivelmanDavid Stokoe
Jun 28, 2002·The Journal of Biological Chemistry·Seiji MabuchiYuji Murata
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Mar 22, 2003·Current Opinion in Cell Biology·James R MitchellLaura J Niedernhofer
Apr 5, 2003·The Journal of Biological Chemistry·Kecheng JiangYolanda Sanchez
Apr 27, 2004·Cell Cycle·Frank W KingEmma Shtivelman
Jun 11, 2004·Annual Review of Biochemistry·Aziz SancarStuart Linn
Nov 9, 2004·Current Opinion in Cell Biology·Clare H McGowan, Paul Russell
Feb 16, 2005·Cancer Cell·Janusz PucRamon Parsons
Nov 30, 2005·Mutagenesis·Hiroyuki Niida, Makoto Nakanishi
Dec 6, 2005·Nature Cell Biology·Ali JazayeriStephen P Jackson
Dec 13, 2005·Molecular & Cellular Proteomics : MCP·Eiji KinoshitaTohru Koike
Apr 25, 2006·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Takashi ShiromizuMasaki Inagaki
Aug 2, 2006·EMBO Reports·Satoko Nishimoto, Eisuke Nishida
Oct 17, 2006·The Biochemical Journal·Gopal P SapkotaDario R Alessi
Nov 8, 2006·Molecular & Cellular Proteomics : MCP·Emiko Kinoshita-KikutaTohru Koike
Jul 3, 2007·Cell·Brendan D Manning, Lewis C Cantley
Oct 20, 2007·Nature Protocols·Hidemasa Goto, Masaki Inagaki
Feb 21, 2008·Nature Reviews. Molecular Cell Biology·Dana Branzei, Marco Foiani
Mar 8, 2008·Science·Thanos D HalazonetisJiri Bartek
Jul 3, 2008·Nature Reviews. Molecular Cell Biology·Karlene A Cimprich, David Cortez
Sep 25, 2008·Nature Reviews. Molecular Cell Biology·Rana Anjum, John Blenis
Nov 6, 2008·Biochemical and Biophysical Research Communications·Yosuke IkegamiMasaki Inagaki
Feb 24, 2009·Current Opinion in Cell Biology·H Christian Reinhardt, Michael B Yaffe
Jul 25, 2009·Nature Reviews. Cancer·Jeffrey A Engelman
Oct 20, 2009·The Journal of Biological Chemistry·Masato EnomotoMasaki Inagaki
Oct 23, 2009·Nature·Stephen P Jackson, Jiri Bartek
Dec 17, 2009·Current Opinion in Genetics & Development·Kwok-Kin WongLewis C Cantley
Dec 23, 2009·Nature Reviews. Molecular Cell Biology·Laura R PearceDario R Alessi
Jul 20, 2010·The EMBO Journal·Kousuke KasaharaMasaki Inagaki
Aug 4, 2010·The Journal of Cell Biology·Naihan XuDavid A Gillespie
Oct 16, 2010·Trends in Biochemical Sciences·Rachel Litman Flynn, Lee Zou
Oct 20, 2010·Molecular and Cellular Biology·Larissa S Moniz, Vuk Stambolic
Oct 23, 2010·Molecular Cell·Alberto Ciccia, Stephen J Elledge

❮ Previous
Next ❯

Citations

Mar 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yu-Che ChengSheau-Yann Shieh
Dec 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Chen ChenSally Kornbluth
Feb 18, 2016·The Journal of Cell Biology·Hironori InabaMasaki Inagaki
Mar 10, 2015·Cell Structure and Function·Hidemasa GotoMasaki Inagaki
Apr 25, 2013·International Journal of Cancer. Journal International Du Cancer·Youwei Zhang, Tony Hunter
Jul 29, 2015·The FEBS Journal·Veronique A J Smits, David A Gillespie
Mar 22, 2015·Mutation Research. Reviews in Mutation Research·Marina A González Besteiro, Vanesa Gottifredi
Oct 5, 2014·Leukemia Research·Ling Li YuanStéphane Manenti
Jun 20, 2015·Cancers·Dennis A SimpsonWilliam K Kaufmann
Jul 7, 2018·Journal of Cell Science·Kévin AdamChristine Didier
Jan 13, 2019·Journal of Cell Science·Hidemasa GotoAkira Mizoguchi
Jul 15, 2015·Nature Communications·Yue ZhouHiroaki Sakurai
Aug 14, 2018·Oncotarget·Bor-Jang HwangA-Lien Lu
Apr 12, 2017·FEBS Open Bio·Mark C de GooijerOlaf van Tellingen
Jul 13, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Triparna SenLauren Averett Byers
Jul 8, 2020·IScience·Takumi MikawaHiroshi Kondoh

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
immunoprecipitation
PCR

Software Mentioned

ImageJ

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.